Medicine | Oncology
Prostate cancer
Prognosis
Prediction tool: Prostate Cancer Risk Index (PRIX)

Home > Disciplines > Medicine > Oncology > Prostate cancer > Prognosis > Prostate Cancer Risk Index (PRIX)

DEFINITION AND VALIDATION

.

Yoshida K, Yamazaki H, Nakamura S, Masui K, Kotsuma T, Akiyama H, Tanaka E, Yoshioka Y.
Role of novel risk classification method, Prostate Cancer Risk Index (PRIX) for clinically localized prostate cancer after high-dose-rate interstitial brachytherapy as monotherapy.
Anticancer Res. 2014 Jun;34(6):3077-81.
Source | Full text | Similar articles

.

Yoshida T, Nakayama M, Matsuzaki K, Kobayashi Y, Takeda K, Arai Y, Kakimoto K, Nishimura K.
Validation of the Prostate Cancer Risk Index (PRIX): a simple scoring system to predict risk of biochemical relapse after radical prostatectomy for prostate cancer.
Jpn J Clin Oncol. 2011 Nov;41(11):1271-6. doi: 10.1093/jjco/hyr139. Epub 2011 Oct 4.
Source | Full text | Similar articles

.

Yoshioka Y, Inoue T.
Prostate Risk Index (PRIX) as a new method of risk classification for clinically localized prostate cancer.
Strahlenther Onkol. 2007 Sep;183(9):490-6. DOI https://doi.org/10.1007/s00066-007-1692-3
Source | Full text | Similar articles

CTC PLUS PROSTATE CANCER RISK INDEX (PRIX)

.

Murray NP, Aedo S, Fuentealba C, Reyes E, Jacob O.
Combining the Prostate Cancer Risk Index (PRIX) with the Presence of Secondary Circulating Prostate Cells to Predict the Risk of Biochemical Failure after Radical Prostatectomy for Prostate Cancer
Asian Pac J Cancer Prev. 2018 Dec 25;19(12):3375-3381.
Source | Full text | Similar articles